The family of a restaurateur who “very likely” died from medication she received for a skin rash are suing the doctor who prescribed the treatment for alleged negligence.

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.

The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for ...

Wockhardt's novel antibiotic Miqnaf approved for CABP treatment, offering a promising monotherapy option for MDR pathogens.

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.

Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment.

Discover why psychiatrists are moving beyond single-treatment approaches and how combining therapies could be the key to ...

Pharmacy benefit managers make decisions about medication access that aren’t always based on the best interests of patients.

The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...